Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression.

MLA

Wagner, Rochelle, et al. “Anti-Inflammatory Interleukin-10 Therapy in CCI Neuropathy Decreases Thermal Hyperalgesia, Macrophage Recruitment, and Endoneurial TNF-Alpha Expression.” Pain, vol. 74, no. 1, Jan. 1998, pp. 35–42. EBSCOhost, https://doi.org/10.1016/S0304-3959(97)00148-6.

APA

Wagner, R., Janjigian, M., & Myers, R. R. (1998). Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain, 74(1), 35–42. https://doi.org/10.1016/S0304-3959(97)00148-6

Chicago

Wagner, Rochelle, Michael Janjigian, and Robert R Myers. 1998. “Anti-Inflammatory Interleukin-10 Therapy in CCI Neuropathy Decreases Thermal Hyperalgesia, Macrophage Recruitment, and Endoneurial TNF-Alpha Expression.” Pain 74 (1): 35–42. doi:10.1016/S0304-3959(97)00148-6.